GlaxoSmithKline Pharmaceuticals P/E Ratio

Current P/E Ratio

41.72

High Valuation

Very High - High growth expectations or significantly overvalued

GlaxoSmithKline Pharmaceuticals (GLAXO) P/E ratio is 41.72 (High), EPS (TTM) ₹61.15, current price ₹2514.30 on NSE vs historical average P/E of 40.05 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see GlaxoSmithKline Pharmaceutical share price chart.

Current Valuation Metrics

P/E Ratio 41.72

Current Price ₹2514.30

EPS (TTM) ₹61.15

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 40.05

Historical Range 17.35 - 55.72

Percentile 66.7%

Sector Context

Sector Average 55.71

Sector Median 31.4

Sector Rank #11 of 194

Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹59.09

Mar 2026 ₹16.40

Sept 2025 ₹15.07

GLAXO P/E Ratio — Valuation Signal & Historical Context

GlaxoSmithKline Pharmaceuticals P/E 41.72 vs historical average 40.05, range 17.35–55.72 — signal: Overvalued. Read GLAXO dividend yield for the complete payout history and dividend yield track record.

Stock appears overvalued with PE of 41.72, suggesting caution for new investments
Trading at discount to sector average PE of 55.71

GlaxoSmithKline Pharmaceuticals P/E Ratio Historical Trend

GLAXO annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 41.72 vs historical average 40.05. See GLAXO book value to compare market price against book value per share.

GLAXO Historical P/E Ratio — EPS, Year-End Price & Valuation

GlaxoSmithKline Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	37.69	59.23	₹2232.10	NSE	High
2024	38.74	50.37	₹1951.55	NSE	High
2023	35.4	37.18	₹1316.30	NSE	High
2022	17.35	100.13	₹1737.15	NSE	Moderate
2021	55.72	28.92	₹1611.50	NSE	High
2020	55.39	29.46	₹1631.85	NSE	High

GLAXO vs Healthcare Peers — P/E Ratio Comparison

GlaxoSmithKline Pharmaceuticals P/E 41.72 vs Healthcare average 55.71, median 31.4 — range 2.86–916.67.

Sector Average

55.71

Sector Median

31.4

Lowest P/E

2.86

Highest P/E

916.67

Companies

194

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Murae Organisor	MURAE	2.86	₹41	Low
Phaarmasia	PHRMASI	3.61	₹64	Low
Sunrest Lifescience	SUNREST	3.76	₹30	Low
Sun Pharma Advanced Rese…	SPARC	4.76	₹7,399	Low
Shelter Pharma	SHELTER	5.23	₹47	Low
Dipna Pharmachem	DPL	5.39	₹14	Low
JFL Life Sciences	JFLLIFE	5.41	₹68	Low
Amwill Health Care	AMWILL	7.26	₹83	Low
Zenith Drugs	ZENITHDRUG	7.69	₹84	Low
Galaxy Medicare	GML	7.8	₹27	Low